However, our research extends this understanding by explicitly linking EPHA2 to the AKT/PI3K signaling pathway and demonstrating that its inhibition can enhance pyroptotic responses in breast cancer cells, a relationship that has not been thoroughly explored in prior research. Here, AKT1 is linked to breast carcinoma.